Regul Pept 167(23):177184 Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour J-F, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Jrvinen H, Fan J-G, Grnbk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng M-H, Fouad Y, Chan W-K, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J (2020) A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Small meals more often help
If you feel fatigued, start with movement gradually
Mounjaro targets both GLP-1 and GIP receptors, improving blood sugar control and supporting weight loss
1 The safety and effectiveness of Wegovy injection have not been established in pediatric patients to reduce the risk of major adverse CV events, to reduce excess body weight and maintain weight reduction long term with the 7.2 mg once-weekly dosage, or to reduce excess body weight and maintain weight reduction long term in those less than 12 years of age
Brighten: Why do you think that these are so effective for your thyroid patients